Stem cells combined with bone graft substitutes in skeletal tissue engineering

Expert Opinion on Biological Therapy

Volumn 12, Issue 6, 2012, Pages 713-729

  Gamie, Zakareya ^a,b   Tran, Gui Tong ^c   Vyzas, George ^d   Korres, Nectarios ^d   Heliotis, Manolis ^e   Mantalaris, Athanasios ^e   Tsiridis, Eleftherios ^d,e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Allograft; Bone; Mesenchymal; Orthopaedics; Progenitor; Stem cell; Substitute

Indexed keywords

CALCIUM PHOSPHATE; GELFOAM; HYDROXYAPATITE; POLYLACTIC ACID; TISSUE SCAFFOLD;

ADIPOSE TISSUE CELL; ADULT STEM CELL; BONE ALLOGRAFT; BONE DEFECT; BONE DEVELOPMENT; BONE GRAFT; BONE MARROW; BONE MARROW CELL; CELL DIFFERENTIATION; CELL ISOLATION; EMBRYONIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MUSCLE CELL; NONHUMAN; OSTEOCYTE; PERIOSTEUM; PLURIPOTENT STEM CELL; PURIFICATION; REVIEW; SKELETAL MUSCLE; TERATOGENESIS; TISSUE ENGINEERING; TREATMENT OUTCOME; UMBILICAL CORD;

ADULT STEM CELLS; ANIMALS; BONE AND BONES; BONE SUBSTITUTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOGENESIS; REGENERATION; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84861308969     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2012.679652     Document Type: Review

References (139)

1. Shenaq DS, Rastegar F, Petkovic D, et al. Mesenchymal progenitor cells and their orthopedic applications: Forging a path towards clinical trials. Stem Cells Int 2010;519028
2. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9
3. Janicki P, Schmidmaier G. What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury 2011;42:S77-81
4. Tsiridis E, Ali Z, Bhalla A, et al. In vitro proliferation and differentiation of human mesenchymal stem cells on hydroxyapatite versus human demineralised bone matrix with and without osteogenic protein-1. Expert Opin Biol Ther 2009;9:9-19
5. Okamoto M, Dohi Y, Ohgushi H, et al. Influence of the porosity of hydroxyapatite ceramics on in vitro and in vivo bone formation by cultured rat bone marrow stromal cells. J Mater Sci Mater Med 2006;17:327-336
6. Hing KA, Revell PA, Smith N, et al. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials 2006;27:5014-5026
7. Hing KA, Wilson LF, Buckland T. Comparative performance of three ceramic bone graft substitutes. Spine J 2007;7:475-490
8. Ohgushi H, Dohi Y, Tamai S, et al. Osteogenic differentiation of marrow stromal stem cells in porous hydroxyapatite ceramics. J Biomed Mater Res 1993;27:1401-1407
9. Matsushima A, Kotobuki N, Tadokoro M, et al. In vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on beta-tricalcium phosphate. Artif Organs 2009;33:474-481
10. Park SH, Tofighi A, Wang X, et al. Calcium phosphate combination biomaterials as human mesenchymal stem cell delivery vehicles for bone repair. J Biomed Mater Res B Appl Biomater 2011;97:235-244
11. Mauney JR, Jaquiery C, Volloch V, et al. In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 2005;26:3173-3185
12. Liu G, Sun J, Li Y, et al. Evaluation of partially demineralized osteoporotic cancellous bone matrix combined with human bone marrow stromal cells for tissue engineering: An in vitro and in vivo study. Calcif Tissue Int 2008;83:176-185
13. Arca T, Proffitt J, Genever P. Generating 3D tissue constructs with mesenchymal stem cells and a cancellous bone graft for orthopaedic applications. Biomed Mater 2011;6:025006
14. Tsiridis E, Ali Z, Bhalla A, et al. In vitro and in vivo optimization of impaction allografting by demineralization and addition of rh-OP-1. J Orthop Res 2007;25:1425-1437
15. Mankani MH, Kuznetsov SA, Wolfe RM, et al. In vivo bone formation by human bone marrow stromal cells: Reconstruction of the mouse calvarium and mandible. Stem Cells 2006;24:2140-2149
16. Mankani MH, Kuznetsov SA, Shannon B, et al. Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol 2006;168:542-550
17. Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-386
18. Marcacci M, Kon E, Moukhachev V, et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 2007;13:947-955
19. Baik KY, Park SY, Heo K, et al. Carbon nanotube monolayer cues for osteogenesis of mesenchymal stem cells. Small 2011;7:741-745
20. McCullen SD, Chow AG, Stevens MM. In vivo tissue engineering of musculoskeletal tissues. Curr Opin Biotechnol 2011;22:715-720
21. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22:560-567
22. Liu G, Li Y, Sun J, et al. In vitro and in vivo evaluation of osteogenesis of human umbilical cord blood-derived mesenchymal stem cells on partially demineralized bone matrix. Tissue Eng Part A 2010;16:971-982
23. Zhao L, Weir MD, Xu HH. Human umbilical cord stem cell encapsulation in calcium phosphate scaffolds for bone engineering. Biomaterials 2010;31:3848-3857
24. Lendeckel S, Jodicke A, Christophis P, et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: Case report. J Craniomaxillofac Surg 2004;32:370-373
25. Bilousova G, Jun du H, King KB, et al. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells 2011;29:206-216
26. Hwang YS, Cho J, Tay F, et al. The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials 2009;30:499-507
27. Kim S, Kim SS, Lee SH, et al. In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly (d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds. Biomaterials 2008;29:1043-1053
28. Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 2001;19:180-192
29. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for cellular therapy position statement. Cytotherapy 2006;8:315-317
30. Kotobuki N, Hirose M, Takakura Y, et al. Cultured autologous human cells for hard tissue regeneration: Preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs 2004;28:33-9
31. Gronthos S, Zannettino AC, Hay SJ, et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003;116:1827-1835
32. Psaltis PJ, Paton S, See F, et al. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. J Cell Physiol 2010;223:530-540
33. Niemeyer P, Kornacker M, Mehlhorn A, et al. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng 2007;13:111-121
34. Nauta AJ, Westerhuis G, Kruisselbrink AB, et al. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006;108:2114-2120
35. Eliopoulos N, Stagg J, Lejeune L, et al. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 2005;106:4057-4065
36. Dos Santos F, Andrade PZ, Boura JS, et al. Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol 2010;223:27-35
37. Morishita T, Honoki K, Ohgushi H, et al. Tissue engineering approach to the treatment of bone tumors: Three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 2006;30:115-118
38. Wu Y, Chen L, Scott PG, et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007;25:2648-2659
39. Gronthos S, McCarty R, Mrozik K, et al. Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: Generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues. Stem Cells Dev 2009;18:1253-1262
40. Muschler GF, Midura RJ. Connective tissue progenitors: Practical concepts for clinical applications. Clin Orthop Relat Res 2002;(395):66-80
41. Vilquin JT, Rosset P. Mesenchymal stem cells in bone and cartilage repair: Current status. Regen Med 2006;1:589-604
42. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986;(205):299-308
43. Faour O, Dimitriou R, Cousins CA, et al. The use of bone graft substitutes in large cancellous voids: Any specific needs? Injury 2011;42:S87-90
44. Arrington ED, Smith WJ, Chambers HG, et al. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996;(329):300-309
45. Graham SM, Leonidou A, Aslam-Pervez N, et al. Biological therapy of bone defects: The immunology of bone allo-transplantation. Expert Opin Biol Ther 2010;10:885-901
46. Janicki P, Kasten P, Kleinschmidt K, et al. Chondrogenic pre-induction of human mesenchymal stem cells on beta-TCP: Enhanced bone quality by endochondral heterotopic bone formation. Acta Biomater 2010;6:3292-3301
47. Kon E, Muraglia A, Corsi A, et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 2000;49:328-337
48. Liu G, Zhao L, Zhang W, et al. Repair of goat tibial defects with bone marrow stromal cells and beta-tricalcium phosphate. J Mater Sci Mater Med 2008;19:2367-2376
49. Zhu L, Liu W, Cui L, et al. Tissue-engineered bone repair of goat-femur defects with osteogenically induced bone marrow stromal cells. Tissue Eng 2006;12:423-433
50. Kruyt MC, Dhert WJ, Yuan H, et al. Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res 2004;22:544-551
51. Kruyt MC, Dhert WJ, Oner FC, et al. Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats. Biomaterials 2007;28:1798-1805
52. Mastrogiacomo M, Papadimitropoulos A, Cedola A, et al. Engineering of bone using bone marrow stromal cells and a silicon-stabilized tricalcium phosphate bioceramic: Evidence for a coupling between bone formation and scaffold resorption. Biomaterials 2007;28:1376-1384
53. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol 2009;218:237-245
54. Zhang H, Ye XJ, Li JS. Preparation and biocompatibility evaluation of apatite/wollastonite-derived porous bioactive glass ceramic scaffolds. Biomed Mater 2009;4:045007
55. Teramoto H, Kawai A, Sugihara S, et al. Resorption of apatite-wollastonite containing glass-ceramic and beta-tricalcium phosphate in vivo. Acta Med Okayama 2005;59:201-207
56. El-Adl G, Mostafa MF, Enan A, et al. Biphasic ceramic bone substitute mixed with autogenous bone marrow in the treatment of cavitary benign bone lesions. Acta Orthop Belg 2009;75:110-118
57. Siegel HJ, Baird RC III, Hall J, et al. The outcome of composite bone graft substitute used to treat cavitary bone defects. Orthopedics 2008;31:754
58. Bajada S, Mazakova I, Richardson JB, et al. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regen Med 2008;2:169-183
59. Goel A, Sangwan SS, Siwach RC, et al. Percutaneous bone marrow grafting for the treatment of tibial non-union. Injury 2005;36:203-206
60. Hernigou P, Mathieu G, Poignard A, et al. Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. J Bone Joint Surg Am 2006;88(Suppl 1 Pt 2):322-327
61. Hernigou P, Poignard A, Beaujean F, et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005;87:1430-1437
62. Bajada S, Harrison PE, Ashton BA, et al. Successful treatment of refractory tibial nonunion using calcium sulphate and bone marrow stromal cell implantation. J Bone Joint Surg Br 2007;89:1382-1386
63. Maneerit J, Meknavin S, Hanpanitkitkan S. Percutaneous versus open bone grafting in the treatment of tibial fractures: A randomized prospective trial. J Med Assoc Thai 2004;87:1034-1040
64. Porter RM, Liu F, Pilapil C, et al. Osteogenic potential of reamer irrigator aspirator (RIA) aspirate collected from patients undergoing hip arthroplasty. J Orthop Res 2009;27:42-9
65. Tzioupis C, Panteliadis P, Gamie Z, et al. Revision of a nonunited subtrochanteric femoral fracture around a failed intramedullary nail with the use of RIA products, BMP-7 and hydroxyapatite: A case report. J Med Case Reports 2011;5:87
66. Fayaz HC, Giannoudis PV, Vrahas MS, et al. The role of stem cells in fracture healing and nonunion. Int Orthop 2011;35:1587-1597
67. Funk JF, Matziolis G, Krocker D, et al. Promotion of bone healing through clinical application of autologous periosteum derived stem cells in a case of atrophic non-union. Z Orthop Unfall 2007;145:790-794
68. Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000;18:959-963
69. Giannoudis PV, Einhorn TA, Marsh D. Fracture healing: The diamond concept. Injury 2007;38(Suppl 4)):S3-6
70. Gie GA, Linder L, Ling RS, et al. Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg Br 1993;75:14-21
71. Korda M, Blunn G, Phipps K, et al. Can mesenchymal stem cells survive under normal impaction force in revision total hip replacements? Tissue Eng 2006;12:625-630
72. Bolland BJ, Partridge K, Tilley S, et al. Biological and mechanical enhancement of impacted allograft seeded with human bone marrow stromal cells: Potential clinical role in impaction bone grafting. Regen Med 2006;1:457-467
73. Korda M, Blunn G, Goodship A, et al. Use of mesenchymal stem cells to enhance bone formation around revision hip replacements. J Orthop Res 2008;26:880-885
74. Arts JJ, Walschot LH, Verdonschot N, et al. Biological activity of tricalciumphosphate/hydroxyl-apatite granules mixed with impacted morsellized bone graft. A study in rabbits. J Biomed Mater Res B Appl Biomater 2007;81:476-485
75. van Haaren EH, Smit TH, Phipps K, et al. Tricalcium-phosphate and hydroxyapatite bone-graft extender for use in impaction grafting revision surgery. An in vitro study on human femora. Bone Joint Surg Br 2005;87:267-271
76. Tsiridis E, Bhalla A, Ali Z, et al. Enhancing the osteoinductive properties of hydroxyapatite by the addition of human mesenchymal stem cells, and recombinant human osteogenic protein-1 (BMP-7) in vitro. Injury 2006;37(Suppl 3):S25-32
77. Munro NA, Downing MR, Meakin JR, et al. A hydroxyapatite graft substitute reduces subsidence in a femoral impaction grafting model. Clin Orthop Relat Res 2007;455:246-252
78. Aulakh TS, Jayasekera N, Kuiper JH, et al. Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty. Biomaterials 2009;30:1732-1738
79. Weinzierl K, Hemprich A, Frerich B. Bone engineering with adipose tissue derived stromal cells. J Craniomaxillofac Surg 2006;34:466-471
80. Xu Y, Malladi P, Wagner DR, et al. Adipose-derived mesenchymal cells as a potential cell source for skeletal regeneration. Curr Opin Mol Ther 2005;7:300-305
81. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: Ten years of research and a literature review. J Nihon Med Sch 2009;76:56-66
82. De Girolamo L, Sartori MF, Arrigoni E, et al. Human adipose-derived stem cells as future tools in tissue regeneration: osteogenic differentiation and cell-scaffold interaction. Int J Artif Organs 2008;31:467-479
83. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 2005;13:845-853
84. Hayashi O, Katsube Y, Hirose M, et al. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif Tissue Int 2008;82:238-247
85. Hattori H, Masuoka K, Sato M, et al. Bone formation using human adipose tissue-derived stromal cells and a biodegradable scaffold. J Biomed Mater Res B Appl Biomater 2006;76:230-239
86. Hattori H, Sato M, Masuoka K, et al. Osteogenic potential of human adipose tissue-derived stromal cells as an alternative stem cell source. Cells Tissues Organs 2004;178:2-12
87. Marino G, Rosso F, Cafiero G, et al. Beta-tricalcium phosphate 3D scaffold promote alone osteogenic differentiation of human adipose stem cells: In vitro study. J Mater Sci Mater Med 2010;21:353-363
88. Gastaldi G, Asti A, Scaffino MF, et al. Human adipose-derived stem cells (hASCs) proliferate and differentiate in osteoblast-like cells on trabecular titanium scaffolds. J Biomed Mater Res A 2010;94:790-799
89. Levi B, James AW, Nelson ER, et al. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One 2010;5:e11177
90. Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-1301
91. Zhang ZY, Teoh SH, Chong MS, et al. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 2009;27:126-137
92. Hass R, Kasper C, Bohm S, et al. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 2011;9:12
93. Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007;25:2886-2895
94. Thein-Han W, Xu HH. Collagen-calcium phosphate cement scaffolds seeded with umbilical cord stem cells for bone tissue engineering. Tissue Eng Part A 2011;17:2943-2954
95. Schneider RK, Puellen A, Kramann R, et al. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials 2010;31:467-480
96. Jankowski RJ, Deasy BM, Huard J. Muscle-derived stem cells. Gene Ther 2002;9:642-647
97. Deasy BM, Jankowski RJ, Huard J. Muscle-derived stem cells: Characterization and potential for cell-mediated therapy. Blood Cells Mol Dis 2001;27:924-933
98. Lee JY, Qu-Petersen Z, Cao B, et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000;150:1085-1100
99. Peng H, Usas A, Gearhart B, et al. Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Mol Ther 2004;9:885-894
100. Usas A, Huard J. Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials 2007;28:5401-5406
101. Peng H, Usas A, Hannallah D, et al. Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4. Mol Ther 2005;12:239-246
102. Usas A, Ho AM, Cooper GM, et al. Bone regeneration mediated by BMP4-expressing muscle-derived stem cells is affected by delivery system. Tissue Eng Part A 2009;15:285-293
103. Adewumi O, Aflatoonian B, Ahrlund-Richter L, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25:803-816
104. zur Nieden NI, Kempka G, Ahr HJ. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 2003;71:18-27
105. Buttery LD, Bourne S, Xynos JD, et al. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 2001;7:89-99
106. Bourne S, Polak JM, Hughes SP, et al. Osteogenic differentiation of mouse embryonic stem cells: Differential gene expression analysis by cDNA microarray and purification of osteoblasts by cadherin-11 magnetically activated cell sorting. Tissue Eng 2004;10:796-806
107. Tai G, Polak JM, Bishop AE, et al. Differentiation of osteoblasts from murine embryonic stem cells by overexpression of the transcriptional factor osterix. Tissue Eng 2004;10:1456-1466
108. Phillips BW, Belmonte N, Vernochet C, et al. Compactin enhances osteogenesis in murine embryonic stem cells. Biochem Biophys Res Commun 2001;284:478-484
109. Ahn SE, Kim S, Park KH, et al. Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem Biophys Res Commun 2006;340:403-408
110. Karp JM, Ferreira LS, Khademhosseini A, et al. Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells 2006;24:835-843
111. Bielby RC, Boccaccini AR, Polak JM, et al. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 2004;10:1518-1525
112. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147
113. Sottile V, Thomson A, McWhir J. In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 2003;5:149-155
114. Hwang YS, Polak JM, Mantalaris A. In vitro direct osteogenesis of murine embryonic stem cells without embryoid body formation. Stem Cells Dev 2008;17:963-970
115. Cao T, Heng BC, Ye CP, et al. Osteogenic differentiation within intact human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days of in vitro culture, and formation of morphologically distinct nodule-like structures. Tissue Cell 2005;37:325-334
116. Bielby RC, Pryce RS, Hench LL, et al. Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with ionic dissolution products of 58S bioactive sol-gel glass. Tissue Eng 2005;11:479-488
117. Xynos ID, Hukkanen MV, Batten JJ, et al. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: Implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-329
118. Gough JE, Jones JR, Hench LL. Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 2004;25:2039-2046
119. Karakoti AS, Tsigkou O, Yue S, et al. Rare earth oxides as nanoadditives in 3-D nanocomposite scaffolds for bone regeneration. J Mater Chem 2010;20:8912-8919
120. Chaudhry GR, Yao D, Smith A, et al. Osteogenic cells derived from embryonic stem cells produced bone nodules in three-dimensional scaffolds. J Biomed Biotechnol 2004;2004:203-210
121. Garreta E, Genove E, Borros S, et al. Osteogenic differentiation of mouse embryonic stem cells and mouse embryonic fibroblasts in a three-dimensional self-assembling peptide scaffold. Tissue Eng 2006;12:2215-2227
122. Smith LA, Liu X, Hu J, et al. The influence of three-dimensional nanofibrous scaffolds on the osteogenic differentiation of embryonic stem cells. Biomaterials 2009;30:2516-2522
123. Alfred R, Taiani JT, Krawetz RJ, et al. Large-scale production of murine embryonic stem cell-derived osteoblasts and chondrocytes on microcarriers in serum-free media. Biomaterials 2011;32: 6006-6016
124. Evans ND, Gentleman E, Chen X, et al. Extracellular matrix-mediated osteogenic differentiation of murine embryonic stem cells. Biomaterials 2010;31:3244-3252
125. Zhang J, Wang M, Cha JM, et al. The incorporation of 70s bioactive glass to the osteogenic differentiation of murine embryonic stem cells in 3D bioreactors. J Tissue Eng Regen Med 2009;3:63-71
126. Jukes JM, Both SK, Leusink A, et al. Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci USA 2008;105:6840-6845
127. Ginis I, Luo Y, Miura T, et al. Differences between human and mouse embryonic stem cells. Dev Biol 2004;269:360-380
128. Tian XF, Heng BC, Ge Z, et al. Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems. Scand J Clin Lab Invest 2008;68:58-67
129. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872
130. Tashiro K, Inamura M, Kawabata K, et al. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 2009;27:1802-1811
131. Namgung S, Baik KY, Park J, et al. Controlling the growth and differentiation of human mesenchymal stem cells by the arrangement of individual carbon nanotubes. ACS Nano 2011;5:7383-7390
132. Geuze RE, Everts PA, Kruyt MC, et al. Orthotopic location has limited benefit from allogeneic or autologous multipotent stromal cells seeded on ceramic scaffolds. Tissue Eng Part A 2009;15:3231-3239
133. Yoshimura H, Muneta T, Nimura A, et al. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007;327:449-462
134. Ball MD, Bonzani IC, Bovis MJ, et al. Human periosteum is a source of cells for orthopaedic tissue engineering: A pilot study. Clin Orthop Relat Res 2011;469:3085-3093
135. Izadpanah R, Trygg C, Patel B, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 2006;99:1285-1297
136. Chang YJ, Shih DT, Tseng CP, et al. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells 2006;24:679-685
137. Levenberg S, Huang NF, Lavik E, et al. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 2003;100:12741-2746
138. Bratt-Leal AM, Carpenedo RL, McDevitt TC. Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog 2009;25:43-51
139. Smith LA, Liu X, Hu J, et al. The enhancement of human embryonic stem cell osteogenic differentiation with nano-fibrous scaffolding. Biomaterials 2010;31:5526-5535